Figure 7
Estimation of chemotherapy response for ccRCC. Docetaxel (a), Gefitinib (b), Methotrexate (c), Paclitaxel (d), Sorafenib (e), Sunitinib (f), Vinblastine (g) and Vorinostat (h).
Figure 7 | Scientific Reports
Estimation of chemotherapy response for ccRCC. Docetaxel (a), Gefitinib (b), Methotrexate (c), Paclitaxel (d), Sorafenib (e), Sunitinib (f), Vinblastine (g) and Vorinostat (h).
